Colin Walsh

Colin Walsh

Direktör/Styrelseledamot på ATTOVIA THERAPEUTICS, INC.
40 år
Health Technology
Finance
Electronic Technology

Profil

Colin Walsh is currently Director at Ceptur Therapeutics, Inc., Managing Director-Life Sciences Investing at The Goldman Sachs Group, Inc. since 2023, Director at Vicebio Ltd. since 2024, Independent Director at Attovia Therapeutics, Inc. since 2024, and Board Member at Element Science, Inc. since 2019.
Former roles include Independent Director at Elevation Oncology, Inc. from 2019 to 2023, Vice President at NanoDimension, Inc., Partner at Qiming US Ventures Management, LLC from 2020 to 2023, Senior Associate at NanoDimension Management Ltd., Principal at Precision NanoSystems, Inc., and Board Member at Korro Bio, Inc. (United States) from 2020 to 2023.
Education includes a doctorate from the University of California, Berkeley and an undergraduate degree from the University of Massachusetts Amherst.

Aktiva positioner av Colin Walsh

FöretagPositionStart
ATTOVIA THERAPEUTICS, INC. Direktör/Styrelseledamot 2024-05-01
THE GOLDMAN SACHS GROUP, INC. Företagsledare/Principal 2023-09-01
Direktör/Styrelseledamot -
Direktör/Styrelseledamot 2019-08-01
Direktör/Styrelseledamot 2024-09-01

Tidigare kända positioner av Colin Walsh

FöretagPositionSlut
Privat kapitalinvesterare 2023-10-31
ELEN ONCO Direktör/Styrelseledamot 2023-09-21
Direktör/Styrelseledamot 2023-09-01
Företagsledare/Principal -
░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Se detaljerna i Colin Walshs erfarenhet

Colin Walshs utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

63

Första gradens relationer

13

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag13

Finance

Electronic Technology

Consumer Services

Finance

Finance

Electronic Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

  1. Börsen
  2. Insiders
  3. Colin Walsh